Keyphrases
Randomized Controlled Trial
100%
Hepatitis C Virus
100%
Community Pharmacy
100%
Opioid Agonist Treatment
100%
Point-of-care
42%
Pharmacy
42%
Hepatitis C Virus RNA
42%
Intention-to-treat
28%
Nurse-led
28%
RNA Testing
28%
Conventional Care
28%
Australia
14%
Scotland
14%
Trial Registration
14%
Wales
14%
RNA Detection
14%
Testing Uptake
14%
Number of Participants
14%
Pharmacist
14%
Hepatitis C Virus Infection
14%
Sustained Virological Response
14%
Direct-acting Antiviral Treatment
14%
Conventional Arms
14%
Mixed-effects Logistic Regression
14%
Community Clinics
14%
Healthcare Models
14%
Point-of-care Diagnosis
14%
Nurse Intervention
14%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Hepatitis C Virus
100%
Community Pharmacy
100%
Opiate Agonist
100%
Virus RNA
42%
Hepatitis C
14%
Antivirus Agent
14%
Nursing and Health Professions
Hepatitis C
100%
Opiate Agonist
100%
Client
57%
Virus RNA
42%
Intention to Treat Analysis
28%
Patient Referral
14%
Logistic Regression Analysis
14%
Antiviral Therapy
14%
Sustained Virologic Response
14%